RA related direct costs (€) per patient-year by cost domains
| Cost domain | Mean (SEM) | Percentage of direct costs | Median | Range |
|---|---|---|---|---|
| DMARDs, disease modifying antirheumatic drugs; NSAIDs, non-steroidal anti-inflammatory drugs. | ||||
| Visits to physicians | 323.5 (9.3) | 14.0 | 300 | 0–972 |
| Outpatient surgery | 3.9 (1.6) | 0.2 | 0 | 0–352 |
| Emergency room visits | 0 | 0 | 0 | 0 |
| Non-physician service use | 2.4 (0.7) | 0.1 | 0 | 0–135 |
| Drugs | 1019.3 (144.1) | 44.1 | 382.7 | 0–28975 |
| DMARDs | 722.7 (138.6) | 31.3 | 189 | 0–27949 |
| Steroids | 46.9 (3.7) | 2.0 | 28 | 0–396 |
| NSAIDs | 83.7 (12.1) | 3.6 | 15 | 0–2693 |
| Osteoporosis drugs | 73.3 (7.8) | 3.2 | 19 | 0–890 |
| Analgesics | 21.7 (5.3) | 0.9 | 0 | 0–1032 |
| Gastroprotective drugs | 71.1 (12.3) | 3.1 | 0 | 0–1960 |
| Diagnostic/therapeutic procedures and test | 185.3 (5.7) | 8.0 | 168.0 | 0–608 |
| Imaging of bones and chest | 27.2 (1.3) | 1.2 | 24.2 | 0–132 |
| Laboratory tests | 140.1 (4.4) | 6.1 | 126.9 | 0–462 |
| Other procedures | 18.0 (1.9) | 0.8 | 7.7 | 0–328 |
| Devices and aids | 168.4 (34.9) | 7.3 | 0 | 0–8712 |
| Acute hospital facilities (without surgery) | 276.1 (79.0) | 11.9 | 0 | 0–19150 |
| Acute hospital facilities (surgery) | 215.1 (67.5) | 9.3 | 0 | 0–15690 |
| Non-acute hospital facilities | 65.3 (27.9) | 2.8 | 0 | 0–6544 |
| Transportation | 52.7 (10.9) | 2.3 | 0 | 0–1921 |
| Home healthcare services | 0 | 0 | 0 | 0 |